Retinal periphlebitis in patients with multiple sclerosis

Miroslav Stamenković1, Dragana Obradović

  • 1University Medical Center Zvezdara, Eye Clinic, Belgrade, Serbia. drmiroslavstamenkovic@gmail.com

Vojnosanitetski Pregled
|September 9, 2011
PubMed
Abstract

Insights

Retinal periphlebitis (RP) is more common in progressive multiple sclerosis (MS) and indicates increased disease activity. Its presence correlates with blood-brain barrier impairment and may help monitor MS progression and treatment effectiveness.

Area of Science:

  • Neuroimmunology
  • Ophthalmology
  • Neurology

Background:

  • Multiple sclerosis (MS) is a central nervous system (CNS) disorder involving inflammation, demyelination, and axonal loss.
  • Retinal periphlebitis (RP) shares histopathological similarities with MS lesions and is frequently observed in MS patients.

Purpose of the Study:

  • To investigate the occurrence of RP in MS patients across different clinical phases.
  • To determine the association between RP and blood-brain barrier (BBB) dysfunction in MS.

Main Methods:

  • Study included 45 MS patients (26 female, 19 male) with varying MS subtypes (RR, PP, SP) and disease phases (relapse, remission).
  • Evaluations included ophthalmological, neurological, and MRI examinations, cerebrospinal fluid analysis, and calculation of albumin ratio and IgG index.

Main Results:

  • RP was present in 9 patients, predominantly in those with longer MS duration and progressive forms.
  • Patients with RP showed elevated albumin ratio and IgG index, indicating increased BBB permeability.
  • Higher visual evoked potential (VEP) latency was observed in the RP group, suggesting neurological impact.

Conclusions:

  • Retinal periphlebitis (RP) serves as a reliable indicator of active multiple sclerosis (MS).
  • RP can be utilized as a parameter for monitoring MS disease activity and treatment efficacy.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...